| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1044210903 |
| P356 | DOI | 10.1186/1465-9921-14-130 |
| P932 | PMC publication ID | 4176098 |
| P698 | PubMed publication ID | 24251953 |
| P5875 | ResearchGate publication ID | 258765179 |
| P50 | author | Tobias Welte | Q64039767 |
| P2093 | author name string | Ralf Lichtinghagen | |
| Marius M Hoeper | |||
| Korbinian Brand | |||
| Nils P Nickel | |||
| Karen M Olsson | |||
| Heiko Golpon | |||
| P2860 | cites work | Increased sympathetic nerve activity in pulmonary artery hypertension | Q64048071 |
| Relation of neurohumoral activation to clinical variables and degree of ventricular dysfunction: a report from the Registry of Studies of Left Ventricular Dysfunction. SOLVD Investigators | Q72676534 | ||
| Arginine vasopressin increases the rate of protein synthesis in isolated perfused adult rat heart via the V1 receptor | Q77965424 | ||
| Arginine vasopressin increases iNOS-NO system activity in cardiac fibroblasts through NF-kappaB activation and its relation with myocardial fibrosis | Q80552379 | ||
| Science review: Vasopressin and the cardiovascular system part 1--receptor physiology | Q21195090 | ||
| Neuroendocrine control of body fluid metabolism | Q28238068 | ||
| Hormones and hemodynamics in heart failure | Q33713907 | ||
| Basic science of pulmonary arterial hypertension for clinicians: new concepts and experimental therapies | Q33849207 | ||
| Anterior and posterior pituitary function testing with simultaneous insulin tolerance test and a novel copeptin assay. | Q34003480 | ||
| Copeptin: clinical use of a new biomarker | Q34010057 | ||
| Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease. | Q34012825 | ||
| Development and Clinical Application of a New Method for the Radioimmunoassay of Arginine Vasopressin in Human Plasma | Q34052781 | ||
| Nucleotide sequence of cloned cDNA encoding bovine arginine vasopressin–neurophysin II precursor | Q34055188 | ||
| Copeptin improves early diagnosis of acute myocardial infarction | Q34113939 | ||
| Assessment of conventional cardiovascular risk factors and multiple biomarkers for the prediction of incident heart failure and atrial fibrillation | Q34421298 | ||
| ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Rev | Q34659902 | ||
| Plasma volume and outcome in pulmonary hypertension | Q34796843 | ||
| Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the In | Q34999923 | ||
| The vasopressin system: physiology and clinical strategies | Q36576783 | ||
| Hyponatremia predicts right heart failure and poor survival in pulmonary arterial hypertension | Q36718655 | ||
| The right ventricle under pressure: cellular and molecular mechanisms of right-heart failure in pulmonary hypertension | Q37407624 | ||
| Dysregulated renin-angiotensin-aldosterone system contributes to pulmonary arterial hypertension | Q37408132 | ||
| Copeptin: a biomarker of cardiovascular and renal function | Q37775088 | ||
| Factors that prognosticate mortality in idiopathic pulmonary arterial hypertension: A systematic review of the literature | Q37784575 | ||
| Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL). | Q38372331 | ||
| Association of copeptin and N-terminal proBNP concentrations with risk of cardiovascular death in older patients with symptoms of heart failure. | Q39984342 | ||
| Atrial natriuretic peptide in heart failure | Q40848699 | ||
| Vasopressin reduces cardiac function and augments cardiopulmonary baroreflex resistance increases in man. | Q40922273 | ||
| Association of serum creatinine with abnormal hemodynamics and mortality in pulmonary arterial hypertension. | Q45719970 | ||
| Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin | Q46790418 | ||
| Possible vascular role of increased plasma arginine vasopressin in congestive heart failure | Q46830711 | ||
| Pathophysiology of lower extremity edema in acute heart failure revisited | Q48399343 | ||
| Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. | Q52422731 | ||
| Neurohormonal activation in patients with right ventricular failure from pulmonary hypertension: Relation to hemodynamic variables and endothelin levels | Q54157002 | ||
| P304 | page(s) | 130 | |
| P577 | publication date | 2013-11-19 | |
| P1433 | published in | Respiratory Research | Q7315904 |
| P1476 | title | Circulating levels of copeptin predict outcome in patients with pulmonary arterial hypertension | |
| P478 | volume | 14 |
| Q38687396 | Association Between Circulating Copeptin Level and Mortality Risk in Patients with Intracerebral Hemorrhage: a Systemic Review and Meta-Analysis |
| Q35556651 | Copeptin testing in acute myocardial infarction: ready for routine use? |
| Q92441305 | Exercise upregulates copeptin levels which is not regulated by interleukin-1 |
| Q33738621 | Kidney dysfunction in patients with pulmonary arterial hypertension |
| Q41368070 | MR-proADM Predicts Exercise Capacity and Survival Superior to Other Biomarkers in PH. |
| Q26744186 | Role of Biomarkers in the Diagnosis, Risk Assessment, and Management of Pulmonary Hypertension |
Search more.